US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Common Sense Fragrance Free Hand Sanitizer

Reason CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.

Aire-Master of America Inc D-1360-2022
Class II · Moderate risk Terminated

Protect U Guard Foaming Hand Sanitizer

Reason CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.

Aire-Master of America Inc D-1359-2022
Class II · Moderate risk Terminated

Protect U Guard Foaming Hand Sanitizer Ophardt

Reason CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.

Aire-Master of America Inc D-1358-2022
Class II · Moderate risk Terminated

Stage 2-Ophardt Foaming Hand Sanitizer

Reason CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.

Aire-Master of America Inc D-1357-2022
Class II · Moderate risk Terminated

Avant Foaming Hand Sanitizer Ophardt

Reason CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.

Aire-Master of America Inc D-1356-2022
Class II · Moderate risk Terminated

Avant Foaming Hand Sanitizer

Reason CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.

Aire-Master of America Inc D-1355-2022
Class II · Moderate risk Terminated

Fulvestrant Injection 250mg/5mL

Reason Failed Impurities/Degradation Specifications

Zydus Pharmaceuticals (USA) Inc NDC 70710-1688-8 D-1351-2022
Class II · Moderate risk Terminated

Difluprednate Ophthalmic Emulsion

Reason Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Cipla NDC 69097-341-35 D-1283-2022
Class II · Moderate risk Terminated

Lorazepam Injection

Reason Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

Hikma Pharmaceuticals USA Inc. NDC 0641-6045-25 D-1310-2022
Class II · Moderate risk Terminated

Lorazepam Injection

Reason Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

Hikma Pharmaceuticals USA Inc. NDC 0641-6048-25 D-1309-2022
Class II · Moderate risk Terminated

Ativan Injection

Reason Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

Hikma Pharmaceuticals USA Inc. NDC 0641-6001-25 D-1308-2022
Class II · Moderate risk Terminated

Lorazepam Injection

Reason Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.

Hikma Pharmaceuticals USA Inc. NDC 0641-6044-25 D-1307-2022
Class II · Moderate risk Terminated

Naftifine Hydrochloride Gel

Reason Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time

Tolmar, Inc. NDC 0115-1510-48 D-1300-2022
Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.

Apotex Corp. NDC 60505-2676-8 D-1285-2022
Class II · Moderate risk Terminated

Succinylcholine Chloride Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC D-1281-2022
Class II · Moderate risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC D-1279-2022
Class II · Moderate risk Terminated

Ropivacaine HCl 123 mg

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC D-1278-2022
Class II · Moderate risk Terminated

Rocuronium Bromide Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC D-1277-2022
Class II · Moderate risk Terminated

Phenylephrine HCl Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC D-1276-2022
Class II · Moderate risk Terminated

Phenylephrine HCl Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC D-1275-2022
Class II · Moderate risk Terminated

Phenylephrine HCl Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC D-1274-2022